Impact of COVID-19 on patients with PiZZ alpha1-antitrypsin deficiency: the IMCA1 study revisited.
Chorostowska-Wynimko, Joanna Corsico, Angelo Esquinas, Cristina Mcelvaney, Gerard Sark, Annelot Sucena, Maria Tanash, Hanan Turner, Alice Miravitlles, Marc
Chorostowska-Wynimko, Joanna
Corsico, Angelo
Esquinas, Cristina
Mcelvaney, Gerard
Sark, Annelot
Sucena, Maria
Tanash, Hanan
Turner, Alice
Miravitlles, Marc
Abstract
IMCA1 concluded that a poor outcome in patients with an AAT level <60mg/dl related to non-respiratory comorbidities more than to markers of respiratory disease1, but deaths only occurred in PiZZ patients.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2023-10-27
Type
Conference Output
Subject
Collections
Citation
European Respiratory Journal 2023 62: PA5107